Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
2019
Abstract Background Pyruvate kinase deficiency is caused by mutations in PKLR and leads to congenital hemolytic anemia. Mitapivat is an oral, small-molecule allosteric activator of pyruvate kinase ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
44
Citations
NaN
KQI